^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    acolbifene

    Associations
    News

    Trials

    Company:
    Endoceutics
    Drug class:
    Selective estrogen receptor modulator
    Related drugs:
    Associations
    News

    Trials

    Apply
    Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer (NCT05941520)
    Phase 2
    National Cancer Institute (NCI)
    Recruiting
    Last update posted :
    02/21/2025
    Initiation :
    08/23/2024
    Primary completion :
    08/23/2027
    Completion :
    09/01/2028
    TP53 • PTEN • ATM • NF1 • MSH6 • CDH1 • CHEK2 • BRIP1 • RAD51C • RAD51D • BARD1 • NBN • AGR2
    |
    TP53 mutation • ATM mutation • CHEK2 mutation • BRIP1 mutation • RAD51C mutation • RAD51D mutation • BARD1 mutation
    |
    tamoxifen • acolbifene
    Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer (NCT00853996)
    Phase 2
    University of Kansas Medical Center
    Completed
    Last update posted :
    01/17/2018
    Initiation :
    02/01/2009
    Primary completion :
    12/01/2010
    Completion :
    12/01/2010
    BRCA1 • BRCA2
    |
    BRCA2 mutation • BRCA1 mutation
    |
    acolbifene